Fight CRC Clinical Trial Finder
| NCT ID | Title | Phase | Date Added | Location | Prior IO Allowed | CRC-directed | Status | Drugs | Tags |
|---|---|---|---|---|---|---|---|---|---|
| NCT ID NCT05491083 |
TitlePembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer | Phase
Phase 1, Phase 2
|
Date Added 2022-08-08 |
Location
Singapore
|
Prior IO Allowed No |
CRC-directed No |
Status
Recruiting
|
Drugs
Pembrolizumab & ADG106 (Phase Ib), Pembrolizumab & ADG106 (Phase II) |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05493683 |
TitleDisitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer | Phase
Phase 2
|
Date Added 2022-08-09 |
Location
China,China,China,China,China,China
|
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Recruiting
|
Drugs
Disitamab vedotin, Tislelizumab |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05611034 |
TitleIn Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung | Phase
Phase 1
|
Date Added 2022-11-09 |
Location
Canada
|
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Recruiting
|
Drugs
oxaliplatin |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05673148 |
TitleTesting the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study | Phase
Phase 3
|
Date Added 2023-01-06 |
Location
Arizona, United States
California, United States Delaware, United States District of Columbia, United States Florida, United States Georgia, United States Idaho, United States Illinois, United States Iowa, United States Kentucky, United States Louisiana, United States Maryland, United States Massachusetts, United States Michigan, United States Minnesota, United States Mississippi, United States Missouri, United States Montana, United States Nebraska, United States Nevada, United States New Hampshire, United States New Jersey, United States New Mexico, United States New York, United States North Carolina, United States North Dakota, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States South Dakota, United States Tennessee, United States Texas, United States Utah, United States Virginia, United States Washington, United States West Virginia, United States Wisconsin, United States |
Prior IO Allowed No |
CRC-directed Yes |
Status
Recruiting
|
Drugs
Chemotherapy |
Tags
MSS/ MMRp
|
| NCT ID NCT05677113 |
TitleA Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver | Phase
Phase 2
|
Date Added 2023-01-10 |
Location
Canada
|
Prior IO Allowed No |
CRC-directed Yes |
Status
Recruiting
|
Drugs
Placebo, QBECO |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05676190 |
TitleClinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer | Phase
Not Applicable
|
Date Added 2023-01-09 |
Location
China
|
Prior IO Allowed No |
CRC-directed Yes |
Status
Recruiting
|
Drugs |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06493760 |
TitleA Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients | Phase
Phase 2
|
Date Added 2024-07-10 |
Location
China
|
Prior IO Allowed No |
CRC-directed Yes |
Status
Recruiting
|
Drugs |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06508307 |
TitleA Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors | Phase
Phase 1
|
Date Added 2024-07-18 |
Location
China
|
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Recruiting
|
Drugs |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06515314 |
TitleHRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors | Phase
Phase 1
|
Date Added 2024-07-23 |
Location
China
|
Prior IO Allowed Yes |
CRC-directed No |
Status
Recruiting
|
Drugs |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06514651 |
TitleMAQ-001 in Patients With Advanced Solid Tumors | Phase
Phase 1
|
Date Added 2024-07-23 |
Location
France
|
Prior IO Allowed Yes |
CRC-directed No |
Status
Recruiting
|
Drugs |
Tags
MSI-H/ MMRd
|
